NCT05177562View on ClinicalTrials.gov

Reproductive Endocrinology Oxford Study (RepOx)

RecruitingOBSERVATIONAL
Enrollment

1,175

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Polycystic Ovary Syndrome
Interventions
OTHER

No intervention

There is no intervention in this study

Trial Locations (1)

OX3 9DU

RECRUITING

Nuffield Department Women's and Reproductive Health, Oxford

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Li Ka Shing Foundation

OTHER

lead

University of Oxford

OTHER

NCT05177562 - Reproductive Endocrinology Oxford Study (RepOx) | Biotech Hunter | Biotech Hunter